Akrotome Imaging, Inc.
- UEI
- KM31KGPYM8Y1
- CAGE
- 66D05
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- akrotome.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir topic 307 phase i novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and | National Cancer Institute (NIH) | $249,912 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Case Western Reserve University | R01CA246678 | $64,377 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Lumicell Inc. | Waltham, MA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Collagen Medical LLC | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Quel Imaging, LLC | Hartford, VT | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Alume Biosciences Inc. | San Diego, CA | — |
| Insight Surgical Technologies Inc. | Lebanon, NH | — |
About the company
Akrotome Imaging, Inc. is a company that specializes in innovative molecular imaging technologies for applications such as optical image guided surgery. They have received federal grants from the National Institutes of Health to support research and development of novel imaging agents and platforms for detecting cancerous tissues during surgery.
Akrotome Imaging has been awarded federal grants as both a prime and subrecipient to advance an imaging platform and associated imaging agents for intraoperative detection of residual breast cancer tissue. Through a prime grant from the National Cancer Institute, the company is developing a fluorescence imaging probe to topically apply in the surgical cavity following lumpectomy procedures, in order to identify residual cancerous tissue that may require further excision. Akrotome Imaging also received a subaward from Case Western Reserve University for a related project to translate this technology into initial clinical evaluation under an Investigational New Drug application. These federal grants support Akrotome Imaging's efforts to commercialize an intraoperative imaging platform and imaging agents to reduce positive surgical margins and cancer recurrence rates for breast cancer patients undergoing breast conserving surgery.
Quick answers
Is Akrotome Imaging, Inc. registered in SAM.gov?
Akrotome Imaging, Inc.'s SAM.gov registration expired on January 14, 2026.
What is Akrotome Imaging, Inc.'s most recent federal award?
Akrotome Imaging, Inc.'s most recent federal grant award is Along the continuum for an IND: an in-vivo large animal study for opticalimage guided surgery of spontaneous breast… (R44CA272087), from National Cancer Institute (NIH), on September 8, 2022.
On GovTribe
See Akrotome Imaging, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors